Moderna | MRNA - Loan Capital


Moderna reported $603M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
Arrowhead Research USD 1.23B 687.3M Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Celltrion KRW 412.27B 348.97B Dec/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 50M 30M Mar/2026
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Incyte USD 29.41M 785K Mar/2026
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 603M 7M Mar/2026
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 33.16M 3.52M Mar/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 838.16M 9.19M Mar/2026
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tilray USD 268.59M 3.82M Sep/2025
Ultragenyx Pharmaceutical USD 1.13B 19M Mar/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026